FBInvestor
Funds / Ingalls & Snyder LLC
Institutional Fund

Ingalls & Snyder LLC

New York, NYCIK 10418855 filings on record

Portfolio Value
$2.82M
Q1 2026
Holdings
453
Reported positions
New Buys
24
Opened this quarter
QoQ Change
+3.9%
from $2.71M

Portfolio Value Trend

Reported 13F value by quarter

Portfolio value trend — upgrade to see history

Upgrade

Top Allocations

Largest positions by weight

  • Corcept Therapeutics Inc10.9%
  • Exxon Mobil Corp4.1%
  • Canadian Nat Res Ltd4.0%
  • Williams Cos Inc3.6%
  • Pan Amern Silver Corp3.5%
  • Alphabet Inc3.1%
  • Other70.8%

Portfolio Holdings

453 positions · Q1 2026

#SecuritySharesValue% Port.Δ SharesActivity
1Corcept Therapeutics Inc7.61M$306.7K10.9%+413.7KAdded
2Exxon Mobil Corp679.4K$115.3K4.1%+20.0KAdded
3Canadian Nat Res Ltd2.34M$113.9K4.0%63.8KReduced
4Williams Cos Inc1.39M$101.3K3.6%+2.2KAdded
5Pan Amern Silver Corp1.78M$97.2K3.5%10.0KReduced
6Alphabet Inc301.6K$86.7K3.1%+584Added
7Apple Inc341.3K$86.6K3.1%3.7KReduced
8Berkshire Hathaway Inc Del174.1K$83.4K3.0%+847Added
9Microsoft Corp195.1K$72.2K2.6%+1.8KAdded
10Jpmorgan Chase & Co.193.5K$56.9K2.0%3.8KReduced

443 more holdings on Premium

See this fund's complete portfolio, full position changes, and activity history.

Unlock full portfolio